Solubility of a drug influences the behavior of compounds in biomedical applications. Poor
solubility of drugs and hydrophobicity along with other bioactive compounds limit their …

A drug is effective in their molecular form; thus solubility in the biological fluid is important.
Pharmaceutical researchers are continuously working on the improvement of solubility of …

Approximately 40% of newly developed drugs are rejected by the pharmaceutical industry
and will never benefit a patient because of low water solubility. Another 17% of launched …

Objective: Dendrimers, a new class of synthetic polymers proved themselves very useful
tools for biomedical application due to their unique characteristics including water solubility …

Adequate aqueous solubility has been one of the desired properties while selecting drug
molecules and other bio-actives for product development. Often solubility of a drug …

Dendrimers are synthetic, absolutely branched, mono‐disperse, unimolecular micellar
architectures with nanometeric dimensions. They are compartmentalized structures with …

Dendrimers are increasingly being investigated as pharmaceutical delivery systems (Figs.
3.1 and 3.2) because of their ability to: improve the solubility and bioavailability of drugs; …

Currently, various types of nanocarriers have been widely used to deliver bioactive
compounds to improve the specificity/effectiveness of the active compound. Among these …

Dendrimers are 3D, hyperbranched, tree-like polymers having immense potential in drug
delivery, targeting, diagnosis and as carriers for DNA/gene delivery. Dendrimers have …

High solubility, high permeability and good stability are basic prerequisites for achieving the
bioavailability and hence therapeutic effectiveness. Newly developed drugs having poor …